| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.79B | 47.69B | 45.76B | 44.54B | 37.73B | 32.44B |
| Gross Profit | 18.24B | 18.77B | 18.20B | 18.33B | 12.92B | 11.03B |
| EBITDA | 8.04B | 7.49B | 8.15B | 7.96B | 6.27B | 3.97B |
| Net Income | 4.39B | 4.84B | 4.47B | 4.46B | 4.26B | 2.40B |
Balance Sheet | ||||||
| Total Assets | 52.67B | 55.84B | 54.15B | 49.10B | 45.25B | 38.45B |
| Cash, Cash Equivalents and Short-Term Investments | 8.35B | 9.98B | 8.88B | 8.39B | 8.93B | 8.78B |
| Total Debt | 3.38B | 4.06B | 2.76B | 2.72B | 2.73B | 2.08B |
| Total Liabilities | 15.19B | 14.36B | 16.04B | 15.58B | 16.38B | 13.20B |
| Stockholders Equity | 37.24B | 41.35B | 37.89B | 33.28B | 28.71B | 25.18B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.51B | 2.70B | 1.48B | 620.28M | 2.08B |
| Operating Cash Flow | 0.00 | 5.25B | 3.46B | 2.56B | 1.91B | 2.71B |
| Investing Cash Flow | 0.00 | -3.39B | -784.01M | -2.49B | -1.52B | -429.19M |
| Financing Cash Flow | 0.00 | -1.28B | -1.88B | -1.85B | -419.04M | -579.34M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥64.67B | 11.67 | ― | 3.95% | 2.75% | 25.75% | |
77 Outperform | ¥69.44B | 11.45 | ― | 2.79% | 4.22% | 7.91% | |
72 Outperform | ¥178.40B | 10.51 | 10.28% | 2.77% | 4.61% | 1.98% | |
67 Neutral | ¥183.15B | 12.84 | 8.17% | 2.04% | 4.34% | 98.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥69.65B | 13.34 | ― | 3.09% | 7.43% | 47.68% | |
60 Neutral | ¥11.98B | 10.62 | ― | 6.70% | -1.89% | -12.80% |